Charitharth Vivek Lal

2.5k total citations · 1 hit paper
51 papers, 1.5k citations indexed

About

Charitharth Vivek Lal is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Charitharth Vivek Lal has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Charitharth Vivek Lal's work include Neonatal Respiratory Health Research (32 papers), Congenital Diaphragmatic Hernia Studies (17 papers) and Respiratory Support and Mechanisms (8 papers). Charitharth Vivek Lal is often cited by papers focused on Neonatal Respiratory Health Research (32 papers), Congenital Diaphragmatic Hernia Studies (17 papers) and Respiratory Support and Mechanisms (8 papers). Charitharth Vivek Lal collaborates with scholars based in United States. Charitharth Vivek Lal's co-authors include Namasivayam Ambalavanan, Gabriel Rezonzew, Vineet Bhandari, Brian Halloran, J. Edwin Blalock, Tomasz Szul, Amit Gaggar, Kristopher R. Genschmer, Xin Xu and Derek W. Russell and has published in prestigious journals such as Cell, Nature Communications and Gastroenterology.

In The Last Decade

Charitharth Vivek Lal

50 papers receiving 1.5k citations

Hit Papers

Activated PMN Exosomes: P... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charitharth Vivek Lal United States 20 935 495 476 209 190 51 1.5k
Jianping Xu China 19 288 0.3× 426 0.9× 267 0.6× 236 1.1× 89 0.5× 81 1.2k
Vicki T. Winter United States 19 1.3k 1.4× 148 0.3× 779 1.6× 148 0.7× 79 0.4× 26 1.7k
Ralph Epaud France 23 1.4k 1.5× 219 0.4× 563 1.2× 163 0.8× 26 0.1× 115 2.1k
Jason S. Debley United States 24 755 0.8× 279 0.6× 218 0.5× 49 0.2× 35 0.2× 62 1.6k
Alfin G. Vicencio United States 18 542 0.6× 254 0.5× 302 0.6× 34 0.2× 37 0.2× 49 1.4k
François Lebargy France 22 803 0.9× 181 0.4× 149 0.3× 36 0.2× 31 0.2× 54 1.5k
Hara Levy United States 20 682 0.7× 243 0.5× 140 0.3× 69 0.3× 55 0.3× 39 1.1k
Beyong Il Kim South Korea 22 1.1k 1.1× 83 0.2× 529 1.1× 425 2.0× 157 0.8× 80 1.8k
M. Malone United Kingdom 23 235 0.3× 187 0.4× 269 0.6× 99 0.5× 75 0.4× 43 1.3k
Mette V. Østergaard Denmark 26 166 0.2× 357 0.7× 542 1.1× 77 0.4× 466 2.5× 52 1.9k

Countries citing papers authored by Charitharth Vivek Lal

Since Specialization
Citations

This map shows the geographic impact of Charitharth Vivek Lal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charitharth Vivek Lal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charitharth Vivek Lal more than expected).

Fields of papers citing papers by Charitharth Vivek Lal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charitharth Vivek Lal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charitharth Vivek Lal. The network helps show where Charitharth Vivek Lal may publish in the future.

Co-authorship network of co-authors of Charitharth Vivek Lal

This figure shows the co-authorship network connecting the top 25 collaborators of Charitharth Vivek Lal. A scholar is included among the top collaborators of Charitharth Vivek Lal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charitharth Vivek Lal. Charitharth Vivek Lal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lal, Charitharth Vivek, et al.. (2023). Clinical Trial of a Probiotic and Herbal Supplement for Lung and Gut Health. A1306–A1306. 1 indexed citations
2.
Willis, Kent A., Kosuke Tanaka, Brian Halloran, et al.. (2023). The Fungal Intestinal Microbiota Predict the Development of Bronchopulmonary Dysplasia in Very Low Birthweight Newborns. A4223–A4223. 1 indexed citations
3.
Patton, Michael J., Carlos J. Orihuela, Kevin S. Harrod, et al.. (2023). COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Critical Care. 27(1). 34–34. 50 indexed citations
4.
Lal, Charitharth Vivek, et al.. (2022). A Live Biotherapeutic Blend Alleviates Neutrophilic Inflammation in Models of COPD. A4671–A4671. 1 indexed citations
5.
Payne, Gregory A., Nirmal Sharma, Charitharth Vivek Lal, et al.. (2021). Prolyl endopeptidase contributes to early neutrophilic inflammation in acute myocardial transplant rejection. JCI Insight. 6(6). 5 indexed citations
6.
Olave, Nelida, Gabriel Rezonzew, Samuel J. Gentle, et al.. (2021). MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha. Respiratory Research. 22(1). 57–57. 13 indexed citations
7.
Willis, Kent A., et al.. (2020). The Closed Eye Harbors a Distinct Microbiome in Dry Eye Disease: A Randomized Clinical Trial of the Efficacy of a Saline Rinse Upon Awakening. Investigative Ophthalmology & Visual Science. 61(7). 3222–3222. 1 indexed citations
8.
Gentle, Samuel J., et al.. (2020). Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia. Respiratory Research. 21(1). 244–244. 2 indexed citations
9.
Willis, Kent A., et al.. (2020). The closed eye harbours a unique microbiome in dry eye disease. Scientific Reports. 10(1). 12035–12035. 49 indexed citations
10.
Genschmer, Kristopher R., Derek W. Russell, Charitharth Vivek Lal, et al.. (2019). Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung. Cell. 176(1-2). 113–126.e15. 336 indexed citations breakdown →
11.
Ding, Jun, Farida Ahangari, Celia R. Espinoza, et al.. (2019). Integrating multiomics longitudinal data to reconstruct networks underlying lung development. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(5). L556–L568. 17 indexed citations
12.
Salas, Ariel A., et al.. (2018). Early progressive feeding in extremely preterm infants: a randomized trial. American Journal of Clinical Nutrition. 107(3). 365–370. 29 indexed citations
13.
Lal, Charitharth Vivek, Jegen Kandasamy, Kalsang Dolma, et al.. (2018). Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 315(5). L810–L815. 47 indexed citations
14.
Ambalavanan, Namasivayam, Gang Liu, Peng Li, et al.. (2017). MicroRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia. American Journal of Respiratory and Critical Care Medicine. 197(5). 632–643. 50 indexed citations
15.
Garg, Parvesh Mohan, Rachel Pinotti, Charitharth Vivek Lal, & Ariel A. Salas. (2017). Transfusion-associated necrotizing enterocolitis in preterm infants: an updated meta-analysis of observational data. Journal of Perinatal Medicine. 46(6). 677–685. 38 indexed citations
16.
Lal, Charitharth Vivek, et al.. (2016). Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity. American Journal of Respiratory Cell and Molecular Biology. 55(4). 602–612. 20 indexed citations
17.
Garg, Parvesh Mohan, et al.. (2015). Necrotizing Enterocolitis (NEC): A Devastating Disease of Prematurity. PubMed. 4(4). 6 indexed citations
18.
Lal, Charitharth Vivek, et al.. (2014). Hypomagnesemia secondary to cerebrospinal fluid losses in a patient with congenital hydrocephalus. Journal of Perinatology. 34(8). 640–641. 1 indexed citations
19.
Lal, Charitharth Vivek & Margaret A. Schwarz. (2014). Vascular mediators in chronic lung disease of infancy: Role of endothelial monocyte activating polypeptide II (EMAP II). Birth Defects Research Part A Clinical and Molecular Teratology. 100(3). 180–188. 10 indexed citations
20.
Lal, Charitharth Vivek, Haiming Xu, George Chenaux, et al.. (2013). Ephrin-B2 Reverse Signaling Increases α5β1 Integrin–Mediated Fibronectin Deposition and Reduces Distal Lung Compliance. American Journal of Respiratory Cell and Molecular Biology. 49(4). 680–687. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026